RecruitingPhase 2NCT07654140

A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Enrollment

252 participants

Start Date

Dec 9, 2025

Study Type

INTERVENTIONAL

Conditions

Uncontrolled Hypertension

Summary

This is a multicenter, randomized, double-blind, placebo-controlled phase II study designed to explore the efficacy and safety of different doses of SAL0140 in uncontrolled hypertension.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo, a drug called SAL0140, and others for people with uncontrolled hypertension. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSAL0140

SAL0140 Tablets

DRUGSAL0140

SAL0140 Tablets

DRUGSAL0140

SAL0140 Tablets

DRUGPlacebo

Placebo

Locations(1)

Beijing Anzhen Hospital Capital Medical University

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07654140

Related Trials

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

NCT0573272740 locations

A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(1)

Related Trials

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Wearable Evaluation of Ambulatory Readings for Blood Pressure

Remote Hypertension Management for Black Patients

Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity